Incidental gonadal tumours at the time of gonadectomy in women with Swyer syndrome: a case series. Journal of Pediatric and Adolescent Gynecology

Similar documents
Female with 46, XY karyotype

Disclosure. Session Objectives. I have no actual or potential conflict of interest in relation to this program/presentation.

COMPLETE GONADAL DYSGENESIS WITH XY CHROMOSOMAL CONSTITUTION

Management of gonads in DSD

Stump the Professors. Professor Panelists 4/13/2015. Challenger. Kylie Fowler, MD

When testes make no testosterone: Identifying a rare cause of 46, XY female phenotype in adulthood

Clinical Standards for Service Planning in PAG

A National Model of Care for Paediatric Healthcare Services in Ireland Chapter 28: Paediatric Gynaecology

Screening for ovarian cancer Kehoe, Sean

Primary Amenorrhea, age 16: Recent Reflections. David A Grainger MD, MPH February 1, 2017

Laura Stewart, MD, FRCPC Clinical Associate Professor Division of Pediatric Endocrinology University of British Columbia

Investigation and treatment of primary amenorrhoea

Rare ovarian tumours Page 1 of 6 Ovacome

BRCA mutation carrier patient: How to manage?

Title: Linitis plastica of the colon due to metastases of invasive lobular breast carcinoma

Disordered Sex Differentiation Mixed gonadal dysgenesis Congenital adrenal hyperplasia Mixed gonadal dysgenesis

ISSN International Journal of Innovative and Applied Research (2017) Journal home page: RESEARCH ARTICLE

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

Surgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk

M Tayfur, R Kocabas, A Kaygisiz, S Tiryaki, M Polat, K Cefle

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

Malignant Ovarian Germ Cell Tumours: Experience in the National University Hospital of Singapore

Cancer and Fertility Ashley Munchel, MD Assistant Professor of Pediatrics University of Maryland Medical Center

Exercise. Discharge Summary

State of the art review in gonadal dysgenesis: challenges in diagnosis and management

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

Case Scenario 1 Discharge Summary Pathology Report Final Diagnosis: Oncology Consult

North of Scotland Cancer Network Clinical Management Guideline for Endometrial Cancer

Accepted Manuscript. Early stage (ct2n0) esophageal cancer: should induction therapy be a standard? Michael Lanuti, MD

Gynaecological Oncology Cases

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

Evidence tables from the systematic literature search for premature ovarian insufficiency surveillance in female CAYA cancer survivors.

and treating joins with the top of canal). at risk for cervical carcinomas, cervix.

PERSISTANT MULLERIAN DUCT SYNDROME ASSOCIATED WITH TRANSVERSE TESTICULAR ECTOPIA

Accepted Manuscript. Ultrasound and adnexal pathology: what is the evidence? Wouter Froyman, MD, Lil Valentin, MD, PhD, Dirk Timmerman, MD, PhD

ANZUP SURVEILLANCE RECOMMENDATIONS FOR METASTATIC TESTICULAR CANCER POST-CHEMOTHERAPY

Proposal form for the evaluation of a genetic test for NHS Service Gene Dossier/Additional Provider

Prospective study evaluating a strategy of surgery alone and surveillance in FIGO stage I malignant ovarian germ cell tumor (KGOG 3033)

X-Plain Ovarian Cancer Reference Summary

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Testicular feminization. The features of this syndrome in its typical form are these (Fig. 1): (1) Female bodily configuration.

A Young Asian Girl with MRKH Type B Syndrome: A Case Report

The Gulf Journal of Oncology

RESEARCH ARTICLE. Usanee Chatchotikawong 1, Irene Ruengkhachorn 1 *, Chairat Leelaphatanadit 1, Nisarat Phithakwatchara 2. Abstract.

46,XY Female: SRY and AR Basis: Genotype & Phenotype Correlation

International Journal of Case Reports in Medicine

Clinical Audit Data: 01 October 2015 to 30 September West of Scotland Cancer Network. Gynaecological Cancer Managed Clinical Network

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

What is ovarian cancer?

Accepted Manuscript. Classical features of Zollinger-Ellison syndrome, in images. Ali Alshati, MD, Toufic Kachaamy, MD

North of Scotland Cancer Network Clinical Management Guideline for Cancer of the Ovary

Primary and secondary amenorrhoea

Bladder Cancer Guidelines

Information for Patients. Primary urethral cancer. English

Normal and Abnormal Development of the Genital Tract. Dr.Raghad Abdul-Halim

GYNECOLOGIC MALIGNANCIES: Ovarian Cancer

PERIPHERAL PRECOCIOUS PUBERTY SECONDARY TO MCCUNE-AL BRIGHT SYNDROME

At the conclusion of the first two year, the resident should be able to:

INFORMATION GUIDE FOR GYNAECOLOGICAL CANCER

Title: unusual case report of inflammatory. fibrous polyps in the upper gastrointestinal tract. Authors: Baifang Wang, Guoqing Xiang, Jia Zhu

The Journal of Minimally Invasive Gynecology. Please cite this article as: Virginie Collin MD, Marie Schaub MD, Emilie Faller MD,

DISORDERS OF MALE GENITALS

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

DEPARTMENT OF ONCOLOGY ELECTIVE

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

1) Intersexuality - Dr. Huda

Paul Hofman. Professor. Paediatrician Endocrinologist Liggins Institute, The University of Auckland, Starship Children Hospital, Auckland

Robbins & Cotran Pathologic Basis Of Disease 8th (egith) Edition Text Only By Vinay Kumar MBBS MD FRCPath READ ONLINE

Female Reproductive Endocrinology

Accepted Manuscript. Surgery for mesothelioma: less is more, more or less. Steven Milman, MD, Thomas Ng, MD

IN SUMMARY HST 071 NORMAL & ABNORMAL SEXUAL DIFFERENTIATION Fetal Sex Differentiation Postnatal Diagnosis and Management of Intersex Abnormalities

Bleomycin, Etoposide and CISplatin (BEP) Therapy

Newton Wellesley Hospital 2013

Staging and Treatment Update for Gynecologic Malignancies

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy

Accepted Manuscript. Risk stratification for distant recurrence of resected early stage NSCLC is under construction. Michael Lanuti, MD

Study Title The SACS trial - Phase II Study of Adjuvant Therapy in CarcinoSarcoma of the Uterus

One of the commonest gynecological cancers,especially in white Americans.

Uterine sarcoma. Information for patients Gynaecology

2016 Uterine Cancer Annual Report

More than meets the eye

Vaginal cancer: Know what to expect

AMBIGUOUS GENITALIA. Dr. HAKIMI, SpAK. Dr. MELDA DELIANA, SpAK

Gynaecological Malignancies

Approach to Disorders of Sex Development (DSD)

Dr Manuela Toledo - Procedures in ART -

Let s Talk About Hormones!

Shared Care Pathway for Soft Tissue Sarcomas Presenting to Site Specialised MDTs. Gynaecological sarcomas Version 1

The Journal of Thoracic and Cardiovascular Surgery

Doppler ultrasound of the abdomen and pelvis, and color Doppler

Triage of Ovarian Masses. Andreas Obermair Brisbane

46 XY gonadal dysgenesis in adulthood pitfalls of late diagnosis

Analysis of Germ Cell Tumors of Ovary in a Tertiary Care Hospital: A Two Year Retrospective Study

Tumori eredofamiliari: sorveglianza di donne ad alto rischio

Treatment outcomes in malignant ovarian germ cell tumors

Testicular cancer and other germ cell tumours. London Cancer Jonathan Shamash

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Case Report Bilateral Breast Masses with a Rare Etiology

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

Transcription:

Accepted Manuscript Incidental gonadal tumours at the time of gonadectomy in women with Swyer syndrome: a case series Amie JM. Hanlon, MBBS Rebecca M. Kimble, MBBS, FRANZCOG PII: S1083-3188(14)00272-1 DOI: 10.1016/j.jpag.2014.07.017 Reference: PEDADO 1754 To appear in: Journal of Pediatric and Adolescent Gynecology Received Date: 25 June 2014 Revised Date: 23 July 2014 Accepted Date: 30 July 2014 Please cite this article as: Hanlon AJ, Kimble RM, Incidental gonadal tumours at the time of gonadectomy in women with Swyer syndrome: a case series, Journal of Pediatric and Adolescent Gynecology (2014), doi: 10.1016/j.jpag.2014.07.017. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

Incidental gonadal tumours at the time of gonadectomy in women with Swyer syndrome: a case series Amie JM Hanlon MBBS 1 & Rebecca M Kimble MBBS, FRANZCOG 2 1 Women s and Newborn Services, Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia 2 Director, Statewide Paediatric and Adolescent Gynaecology Services, Royal Brisbane and Women s Hospital, Brisbane, Queensland, Australia; University of Queensland School of Medicine Abstract Background: Swyer syndrome (46XY complete gonadal dysgenesis) is an uncommonly encountered condition in our population. Gonadectomy is recommended upon diagnosis due to a significant risk of malignant transformation of the dysgenetic gonads, typically to dysgerminoma. Cases: We present 3 cases of women who underwent gonadectomy following a diagnosis of Swyer syndrome. Two of these patients had dysgerminoma confirmed on histopathology. In particular we discuss the macroscopic appearance of the affected gonads and the further management of each case. Summary and Conclusion: Individuals with Swyer syndrome require gonadectomy upon diagnosis of their condition, as part of their multidisciplinary management. For treatment of early stage dysgerminoma, surgical resection of the involved gonad and fallopian tube is curative, again highlighting the need for early intervention.

Introduction Swyer syndrome, or 46XY complete gonadal dysgenesis, affects approximately 1 in 30,000-1 in 80,000 women. 1,2 Individuals with Swyer syndrome are phenotypical females, with female genitalia at birth and normal Müllerian structures. These women usually present during adolescence with delayed puberty and primary amenorrhoea, often accompanied by tall stature. The psychosocial and reproductive implications of the condition require multidisciplinary management involving pubertal induction, psychosocial support and assisted reproductive technologies; in addition, the dysgenetic, characteristically streak gonads have a 30% risk of development of gonadoblastoma with a 50-60% risk of malignant transformation, typically to dysgerminoma. 3,4,5,6 Therefore, prophylactic gonadectomy is recommended upon diagnosis. The Statewide Paediatric and Adolescent Gynaecology (PAG) Service at the Royal Brisbane and Women s Hospital (RBWH), Queensland, Australia, has managed four women with a diagnosis of Swyer syndrome since its inception in 2001. Here we report on laparoscopic and pathologic findings of gonadectomy and salpingectomy in three of the four women, whose histology revealed incidental findings of gonadal tumours of varying severity. The report will also discuss their further management and follow-up.

Case 1 The patient was first seen in the PAG clinic aged 17years, 9 months, having been referred by a paediatric endocrinologist after investigation for primary amenorrhoea. On examination, she had Tanner stage 3 breast development, Tanner stage 5 pubic hair, and normal female external genitalia, with a probe passed approximately 5cm into the vagina. FSH was 88 U/l (1.0-8.0), LH 26 U/l (1.0-12.0), oestradiol <30 pmol/l, and a 46XY karyotype was confirmed on 2 occasions. LDH was increased pre-operatively at 277 U/l (105-230). Pelvic MRI revealed a small uterus with bilateral gonads visualised. She underwent laparoscopic bilateral gonadectomy and salpingectomy; bilateral streak gonads were noted intraoperatively. Histology revealed bilateral foci of gonadoblastoma with no evidence of invasive germ cell tumour. She was commenced on a low-dose combined oral contraceptive pill after advice was sought from haematology regarding a prothrombin gene mutation on thrombophilia screening (prothrombin 20210G>A heterozygosity). The patient became sexually active aged 19 years with no problems, and has been well on followup since. Case 2 The patient was initially seen in the PAG clinic aged 15 years, 8 months, having been referred by a paediatric endocrinologist who had investigated her primary amenorrhoea. She had been investigated for abdominal pain approximately 6 months prior to seeing the endocrinologist and had been treated for Helicobacter pylori infection. Pelvic ultrasound at that time had revealed a small uterus and ovaries. On

examination, she was 161cm tall and weighed 53kg, with a BMI of 20.5 kg/m 2. She had Tanner stage 2 breasts and stage 3 pubic hair, with scant axillary hair. The external genitalia had a normal female appearance and a probe was passed approximately 5cm into the vagina. FSH was 58 U/l, LH 23 U/l, oestradiol 53 pmol/l, and karyotype 46XY on 2 occasions. LDH was normal at 194 and was never increased beyond the reference range. Pelvic MRI revealed female genitalia with volumes of the right ovary and uterus at or just below the reference range for pubertal structures; the left ovary was not identified. The patient underwent laparoscopic gonadal biopsy operation findings included a small, normal uterus; a left streak gonad (Fig. 1); and a right gonad of abnormal appearance with creamy-yellow surface excrescences, which appeared nodular (Fig. 2). The rest of the abdomen and pelvis appeared normal. Histology of the right gonadal biopsy confirmed a dysgerminoma, described macroscopically as granular cream and tan tissue, arising from a gonadoblastoma, with the left ovary containing gonadoblastoma only. She went on to have laparoscopic bilateral gonadectomy and salpingectomy, and staging, performed by gynaecology-oncology 5 days later. Histology confirmed the previous findings, and peritoneal washings were positive for dysgerminoma cells. This gave her a diagnosis of Stage IC gonadal dysgerminoma, and she underwent 3 cycles of BEP (bleomycin, etoposide and cisplatin) chemotherapy with her local medical oncologist. The patient was commenced on the combined oral contraceptive pill after finishing chemotherapy, which induced menses, and became sexually active at age 16 years, 8 months with no problems. She has been well on follow-up by PAG and gynaecologyoncology since.

Case 3 The patient was first seen in the PAG clinic aged 15 years, 11 months having been referred by the paediatric endocrinologist who investigated her primary amenorrhoea. She was 174cm tall, and weighed 66.7kg, with a BMI of 22 kg/m 2. She had Tanner stage 1 breast and pubic hair, and no axillary hair. External genitalia had a normal female appearance and a probe was passed into the vagina its entire length. FSH was 99 U/l, LH 44 U/l, oestradiol <37 pmol/l and karyotype was confirmed as 46XY on two occasions. LDH was 211 pre-op and was never above the reference range. Pelvic USS was unable to demonstrate uterus and ovaries; kidneys were normal. Bone age was performed and was consistent with 11.5 years. A pelvic MRI revealed a very small hypoplastic or rudimentary uterus with a probable short segment of upper vaginal canal, but mid- and lower vaginal canal not confidently identified, and a probable small right ovary with no left ovary identified; the renal tract was normal. The patient underwent laparoscopic bilateral gonadectomy and salpingectomy during which bilateral streak gonads were identified with the left being slightly yellow in appearance and containing a nodule (Figs. 3 and 4). There was a small rudimentary uterus. Histology of the left gonad revealed dysgerminoma, described macroscopically as a small yellow nodule, arising from gonadoblastoma. As the tumour wasn t surgically staged she underwent CT chest, abdomen and pelvis which were normal. Her case was referred the tumour board meeting of the RBWH gynaecology-oncology service and, given the tiny focus of dysgerminoma, a decision was made for long-term surveillance with regular tumour markers and yearly pelvic

MRIs, with no adjuvant treatment currently. Pubertal induction with oestradiol was commenced under the supervision of paediatric endocrinology, with a view to adding progesterone after 12 months of oestrogen replacement, and the patient was well at her recent post-operative follow-up. Summary and Conclusion This case series highlights the importance of prophylactic gonadectomy at diagnosis in women with Swyer syndrome. This condition is not commonly encountered in our population, with just four cases managed by our service in 13 years. The complex, multidisciplinary management of this condition includes gonadectomy, recommended at diagnosis due to the substantial risk of malignant transformation. The outcomes for our small population of women with Swyer syndrome are consistent with the stated risk of malignancy in the literature: of four women with the syndrome, three had incidental gonadal tumours at gonadectomy, two of which were malignant. Dysgerminoma is the most common malignant germ cell tumour arising from dysgenetic gonads, and is described grossly as a yellow-white to grey-pink, often soft and fleshy mass, consistent with the laparoscopic findings presented here. 7 Early stage disease may be successfully treated with surgical resection of the involved gonad and fallopian tube, ideally with staging performed concurrently. 8 The two-stage procedure performed for the patient in Case 2 is not standard management, and simply reflects a lack of experience in managing women with Swyer syndrome at the time, as this patient was the first case managed by our service. Advanced stage disease can similarly be cured using platinum-based chemotherapy, to which as malignant germ

cell tumours are highly sensitive. 8 This again reinforces the current recommendation for gonadectomy at diagnosis in the setting of 46XY gonadal dysgenesis, as diagnosing any germ cell tumour early in its course allows for a less aggressive treatment approach. References 1. Swyer syndrome. Genetics Home Reference, A service of the U.S. National Library of Medicine.http://ghr.nlm.nih.gov/condition/swyer-syndrome 2. Michala L, Goswami D, Creighton SM, et al: Swyer syndrome: presentation and outcomes. BJOG 2008; 115:737 3. Jorgensen PB, Kjartansdottir KR, Fedder J: Care of women with XY karyotype: a clinical practice guideline. Fert & Ster 2010; 94(1):105 4. Marsh CA, Smith YR: Gonadal dysgenesis. In: Practical Pediatric and Adolescent Gynecology. Edited by Paula J Adams Hillard. West Sussex, Wiley-Blackwell, 2013, pp 366-370 5. Massanyi EZ, DiCarlo HN, Migeon CJ, et al: Review and management of 46,XY disorders of sex development. J Ped Urol 2013; 9:368 6. Michala L, Creighton SM: The XY female. Best Prac Res Clin Ob Gyn 2010; 24:139 7. Ellenson LH, Pirog EC: The female genital tract. In: Robbins and Cotran Pathologic Basis of Disease, (8 th ed.). Edited by Vinay Kumar, Abul K Abbas, Nelson Fausto, Jon C Aster. Philadelphia, Elsevier Saunders, 2010, pp 1005-1064

8. Chalas E, Valea FA, Mann WJ: Treatment of malignant germ cell tumours of the ovary. UpToDate 2013

Figure Legends Figure 1. Left streak gonad (grasped) containing gonadoblastoma, Case 2 Figure 2. Right gonad containing dysgerminoma arising from gonadoblastoma, Case 2 Figure 3. Right streak gonad, no tumour present, Case 3 Figure 4. Left streak gonad containing dysgerminoma arising from gonadoblastoma, Case 3